CELIA, Christian
 Distribuzione geografica
Continente #
NA - Nord America 276
EU - Europa 218
AS - Asia 154
SA - Sud America 2
Totale 650
Nazione #
US - Stati Uniti d'America 272
IT - Italia 143
SG - Singapore 106
CN - Cina 27
GB - Regno Unito 17
DE - Germania 13
SE - Svezia 13
IN - India 10
HK - Hong Kong 9
NL - Olanda 8
FI - Finlandia 7
CA - Canada 3
DK - Danimarca 3
FR - Francia 3
RO - Romania 3
AT - Austria 2
CL - Cile 2
EE - Estonia 2
CZ - Repubblica Ceca 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
TW - Taiwan 1
UA - Ucraina 1
Totale 650
Città #
Chandler 56
Singapore 39
Ashburn 27
Milan 24
Santa Clara 24
Senigallia 18
Boardman 17
Princeton 12
London 10
Catanzaro 9
Lawrence 9
Hong Kong 8
Seattle 8
Wilmington 8
Wuhan 8
Helsinki 7
Rome 6
West Jordan 6
Naples 5
Palermo 5
Pune 5
Buffalo 4
Chicago 4
Enfield 4
Los Angeles 4
Montauro 4
Mumbai 4
San Nicola Manfredi 4
Shanghai 4
Bisignano 3
Copenhagen 3
Lamezia Terme 3
Munich 3
Afragola 2
Dianzicheng 2
Florence 2
Horia 2
Redmond 2
San Sostene 2
Tartu 2
Amsterdam 1
Augusta 1
Aversa 1
Bari 1
Berlin 1
Brent 1
Chengdu 1
Chiba 1
Cosenza 1
Council Bluffs 1
Des Moines 1
Dongguan 1
Dongyang 1
Esslingen am Neckar 1
Fayetteville 1
Guangzhou 1
Handan 1
Hanover 1
Kaunas 1
Mexico City 1
Montreal 1
Nagold 1
Napoli 1
New York 1
Norwalk 1
Nuremberg 1
Ottawa 1
Padova 1
Phoenix 1
Quanzhou 1
Salerno 1
Settingiano 1
State College 1
Szeged 1
Taranto 1
The Dalles 1
Toronto 1
Treviso 1
Vallefiorita 1
Verona 1
Vienna 1
Washington 1
Watertown 1
Yunfu 1
Totale 413
Nome #
Pro-drug innovativo micellare su backbone polimerico del Killer TNF-apoptosis induced ligand. 78
Pegilazione innovativa del killer TNF-apoptosis induced ligand (killer-trail). 74
Sistema liposomiale con Killer TNF-apoptosis induced ligand (KillerTRAIL), pro-apoptotico-direzionante 55
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis 47
Nanonutraceuticals: The new frontier of supplementary food 35
Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes 34
pH-responsive chitosan based hydrogels affect the release of dapsone: Design, set-up, and physicochemical characterization 30
Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer 30
LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy 29
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 28
Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery 25
Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and in vitro cytotoxicity 24
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 23
C-end rule peptide-guided niosomes for prostate cancer cell targeting 20
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 20
Icariin-Loaded Transfersomes® as a Potential Nanomedicine for Skin Disorders 17
OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline 16
Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol 15
Skin Tolerability of Oleic Acid Based Nanovesicles Designed for the Improvement of Icariin and Naproxen Percutaneous Permeation 15
Assessing effectiveness of multistage nanomedicines for multidrug therapy of vitiligo 15
Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes 14
Praziquantel-loaded calcite crystals: Synthesis, physicochemical characterization, and biopharmaceutical properties of inorganic biomaterials for drug delivery 13
Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models 12
Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds 9
Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles 7
Multidrug Idebenone/Naproxen Co-loaded Aspasomes for Significant in vivo Anti-inflammatory Activity 7
null 6
Conventional Nanosized Drug Delivery Systems for Cancer Applications 3
Conventional Nanosized Drug Delivery Systems for Cancer Applications 1
Totale 702
Categoria #
all - tutte 7.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202172 0 0 0 0 0 0 23 8 31 6 3 1
2021/202245 7 0 6 10 3 0 2 8 6 0 2 1
2022/2023134 21 15 11 10 14 13 0 3 17 3 24 3
2023/2024163 21 5 10 6 8 33 1 10 12 13 2 42
2024/2025286 38 7 12 19 36 38 24 16 83 9 4 0
Totale 702